Adipose Tissue Insulin Resistance in Gestational Diabetes.

ABSTRACT:

Background

Gestational diabetes mellitus (GDM) is a metabolic disorder characterized by insulin resistance (IR) and altered glucose-lipid metabolism. We propose that ectonucleotide pyrophosphate phosphodiesterase-1 (ENPP1), a protein known to induce adipocyte IR, is a determinant of GDM. Our objective was to study ENPP1 expression in adipose tissue (AT) of obese pregnant women with or without GDM, as well as glucose tolerance in pregnant transgenic (Tg) mice with AT-specific overexpression of human ENPP1.

Methods

AT biopsies and blood were collected from body mass index-matched obese pregnant women non-GDM (n?=?6), GDM (n?=?7), and nonpregnant controls (n?=?6) undergoing cesarian section or elective surgeries, respectively. We measured the following: (1) Expression of key molecules involved in insulin signaling and glucose-lipid metabolism in AT; (2) Plasma glucose and insulin levels and calculation of homeostasis model assessment of IR (HOMA-IR); (3) Intraperitoneal glucose tolerance test in AtENPP1 Tg pregnant mice.

Results

We found that: (1) Obese GDM patients have higher AT ENPP1 expression than obese non-GDM patients, or controls (P?=?0.01-ANOVA). (2) ENPP1 expression level correlated negatively with glucose transporter 4 (GLUT4) and positively with insulin receptor substrate-1 (IRS-1) serine phosphorylation, and to other adipocyte functional proteins involved in glucose and lipid metabolism (P?glucose).

Conclusions

Our results provide evidence of a causative link between ENPP1 and alterations in insulin signaling, glucose uptake, and lipid metabolism in subcutaneous abdominal AT of GDM, which may mediate IR and hyperglycemia in GDM.

SUBMITTER: Tumurbaatar B 

PROVIDER: S-EPMC5333579 | biostudies-literature | 2017 Mar

REPOSITORIES: biostudies-literature